TPST
Tempest Therapeutics, Inc.NASDAQHealthcare$1.56+0.00%ClosedMarket Cap: $6.9M
As of 2026-04-09
Valuation
P/E (TTM)
—
PEG
—
P/B
0.97
P/S
0.00
EV/EBITDA
-0.29
DCF Value
$-0.34
FCF Yield
-689.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-309.6%
ROA
-155.1%
ROIC
-179.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-4.1M | $-4.0M | $-0.82 | — |
| FY 2025 | $0.00 | NaN% | $-26.6M | $-26.3M | $-6.33 | — |
| Q3 2025 | $0.00 | -Infinity% | $-3.6M | $-3.5M | $-0.79 | — |
| Q2 2025 | $0.00 | -Infinity% | $-8.0M | $-7.9M | $-2.07 | — |
| Q1 2025 | $0.00 | NaN% | $-10.9M | $-10.9M | $-3.16 | — |
| Q4 2024 | $0.00 | NaN% | $-13.9M | $-13.8M | $-0.50 | — |
| FY 2024 | $0.00 | -Infinity% | $-42.0M | $-41.8M | $-1.50 | — |
| Q3 2024 | $0.00 | NaN% | $-10.6M | $-10.6M | $-0.41 | — |
| Q2 2024 | $0.00 | NaN% | $-9.6M | $-9.6M | $-0.42 | — |
| Q1 2024 | $0.00 | NaN% | $-8.0M | $-7.9M | $-0.36 | — |
| Q4 2023 | $0.00 | NaN% | $-7.5M | $-7.5M | $-0.35 | — |
| FY 2023 | $0.00 | NaN% | $-29.2M | $-29.5M | $-1.91 | — |